| 000 | 01588 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515011534.0 | ||
| 264 | 0 | _c20060629 | |
| 008 | 200606s 0 0 eng d | ||
| 022 | _a1462-0324 | ||
| 024 | 7 |
_a10.1093/rheumatology/kei260 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVos, P A J M | |
| 245 | 0 | 0 |
_aCost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice. _h[electronic resource] |
| 260 |
_bRheumatology (Oxford, England) _cMay 2006 |
||
| 300 |
_a629-35 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Evaluation Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibodies, Antinuclear _xblood |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xdiagnosis |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDNA _ximmunology |
| 650 | 0 | 4 |
_aFluorescent Antibody Technique, Indirect _xeconomics |
| 650 | 0 | 4 |
_aHealth Care Costs _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoassay _xeconomics |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 700 | 1 | _aBast, E J E G | |
| 700 | 1 | _aDerksen, R H W M | |
| 773 | 0 |
_tRheumatology (Oxford, England) _gvol. 45 _gno. 5 _gp. 629-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kei260 _zAvailable from publisher's website |
| 999 |
_c15987880 _d15987880 |
||